Arch Phys Med Rehabil

1. BAE M, Ku B, VanNostrand M, Kasser SL, et al
   Home-based Balance Training on Balance and Mobility in Persons with Multiple Sclerosis: A Systematic Review and Meta-analysis.
   Arch Phys Med Rehabil. 2024 May 27:S0003-9993(24)01015.
   

   >> Share

   
   

   
   J Neurol

2. PORTACCIO E, Betti M, De Meo E, Addazio I, et al
   Progression independent of relapse activity in relapsing multiple sclerosis: impact and relationship with secondary progression.
   J Neurol. 2024 May 28. doi: 10.1007/s00415-024-12448.
   

   >> Share

   
   

   
   J Neurol Sci

3. PIEDRABUENA MA, Correale J, Fiol M, Marrodan M, et al
   Selection of disease modifying therapies in multiple sclerosis based on patient's age and disease activity: Data from a nationwide registry.
   J Neurol Sci. 2024;461:123052.
   

   >> Share

   
   

   
   Magn Reson Med

4. SHEN X, Caverzasi E, Yang Y, Liu X, et al
   3D balanced SSFP UTE MRI for multiple contrasts whole brain imaging.
   Magn Reson Med. 2024;92:702-714.
   

   >> Share

   
   

   
   Mult Scler

5. FOSTER MA, Prados F, Collorone S, Kanber B, et al
   Improving explanation of motor disability with diffusion-based graph metrics at onset of the first demyelinating event.
   Mult Scler. 2024;30:800-811.
   

   >> Share

   
   
6. MONTOBBIO N, Bovis F, Signori A, Ponzano M, et al
   Therapeutic lag: Is treatment effect delayed in progressive MS?
   Mult Scler. 2024;30:843-846.
   

   >> Share

   
   
7. PAPPOLLA A, Auger C, Sao-Aviles A, Tur C, et al
   Prediction of disease activity and treatment failure in relapsing-remitting MS patients initiating daily oral DMTs.
   Mult Scler. 2024 Mar 29:13524585241240653. doi: 10.1177/13524585241240653.
   

   >> Share

   
   
8. PFEUFFER S
   Psoriasisform dermatitis following anti-CD20 therapies: Immunologic lessons and management dilemmas.
   Mult Scler. 2024;30:897-898.
   

   >> Share

   
   

   
   Neurol Genet

9. MISICKA E, Huang Y, Loomis S, Sadhu N, et al
   Adaptive and Innate Immunity Are Key Drivers of Age at Onset of Multiple Sclerosis.
   Neurol Genet. 2024;10:e200159.
   

   >> Share

   
   

   
   PLoS One

10. HARRISON DM, Allette YM, Zeng Y, Cohen A, et al
    Meningeal contrast enhancement in multiple sclerosis: Assessment of field strength, acquisition delay, and clinical relevance.
    PLoS One. 2024;19:e0300298.
    

    >> Share

    
    

    
    Rev Neurol

11. APARICIO-CASTRO E, Candeliere-Merlicco A, Maria Santa C, Villaverde-Gonzalez R, et al
    [Usefulness of the Beck depression inventory in the diagnosis of depressive disorders in multiple sclerosis].
    Rev Neurol. 2024;78:317-322.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share